Radiopharmaceutical Market (Updated Version Available)

The report offers detailed coverage of Radiopharmaceutical industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Radiopharmaceutical by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.


The report forecast global Radiopharmaceutical market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Radiopharmaceutical market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea


At the same time, we classify Radiopharmaceutical according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Market by Application
Oncology
Cardiology
Other

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Radiopharmaceutical market for the forecast period 2021 - 2025?
• What are the driving forces in the Radiopharmaceutical market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Radiopharmaceutical industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?